Dimensional Fund Advisors LP Buys 290,589 Shares of Healthpeak Properties, Inc. $DOC

Dimensional Fund Advisors LP lifted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 2.8% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 10,583,736 shares of the real estate investment trust’s stock after buying an additional 290,589 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Healthpeak Properties were worth $173,896,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Integrated Wealth Concepts LLC raised its holdings in Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after acquiring an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Healthpeak Properties by 110.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after acquiring an additional 63,930 shares during the period. Woodline Partners LP boosted its holdings in shares of Healthpeak Properties by 41.3% during the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after acquiring an additional 17,279 shares during the period. Brown Advisory Inc. grew its position in shares of Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after purchasing an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Healthpeak Properties in the second quarter valued at approximately $3,117,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.23% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on DOC shares. Royal Bank Of Canada increased their target price on Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research note on Thursday, May 14th. Scotiabank boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. UBS Group upped their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Finally, Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $20.62.

Healthpeak Properties Stock Up 1.0%

NYSE DOC opened at $22.29 on Friday. The business has a fifty day moving average price of $20.74 and a two-hundred day moving average price of $18.45. The stock has a market capitalization of $15.37 billion, a PE ratio of 69.67, a PEG ratio of 3.46 and a beta of 1.02. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.77.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. During the same quarter in the previous year, the business posted $0.46 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts expect that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.5%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.